Glassman Wealth Services’s Antares Pharma, Inc. ATRS Stock Holding History

Glassman Wealth Services’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-58	Closed	–	–	2127
2022 Q1	$0	Buy	+58	New	+$210	﹤0.01%	2061
2021 Q4	–	Sell	-42	Closed	–	–	2033
2021 Q3	$0	Hold	42	–	–	﹤0.01%	1900
2021 Q2	$0	Buy	+42	New	+$171	﹤0.01%	1734

Other funds holding ATRS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glassman Wealth Services's ATRS Position: Q2 2022 in Review

Glassman Wealth Services sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 58 shares.

Glassman Wealth Services first reported a position in ATRS in Q2 2021 and held it in 3 quarters. The position peaked at $0 in Q1 2022. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

Glassman Wealth Services reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
Glassman Wealth Services sold 58 Antares Pharma, Inc. shares in Q2 2022.
Glassman Wealth Services first reported a position in Antares Pharma, Inc. in Q2 2021 and held it in 3 quarters.
Glassman Wealth Services's Antares Pharma, Inc. position peaked at $0 in Q1 2022.
1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Glassman Wealth Services's 13F filing for Q2 2022, filed 4 Aug 2022.